In vivo bone formation by human alveolar‐bone‐derived mesenchymal stem cells obtained during implant osteotomy using biphasic calcium phosphate ceramics or Bio‐Oss as carriers
- 1 May 2015
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 104 (3) , 515-524
Abstract
Objectives: The aim of this study was to evaluate HA coated with different ratios of TCP as a carrier for hABMSCs obtained during implant osteotomy in comparison to slowly‐resorbing biomaterial, Bio‐Oss, as a negative control, using in vitro and in vivo experiments.Materials and Methods: Human ABMSCs (hABMSCs) harvested during implant osteotomy were transplanted using HA/TCP or Bio‐Oss as carriers in a murine ectopic transplantation model (n = 12). Pore size and cell affinity were evaluated in vitro. The area of newly formed bone was analyzed histometrically, the number of osteocytes was counted, and immunohistochemical staining was conducted against several markers of osteogenesis, including alkaline phosphatase (ALP), runt‐related transcription factor 2 (RUNX‐2), osteocalcin (OCN), and osteopontin (OPN). Osteoclast formation was evaluated by tartrate‐resistant acid phosphatase staining.Results: The carrier materials had comparable pore sizes. The cell affinity assay resulted in a high proportion of cell adhesion (>90%) in all experimental groups. Substantial new bone and osteocyte formation was observed on both HA/TCP carriers, whereas it was minimal with Bio‐Oss. Positive immunostaining for ALP, RUNX‐2, OCN, and OPN was observed with HA/TCP, but only limited expression of osteogenic markers with Bio‐Oss. Conversely, there was a minimal osteoclast presence with Bio‐Oss, but a significant presence of osteoclasts with both HA/TCP carriers.Conclusions: Both types of scaffolds, BCP and Bio‐Oss, showed high stem cell‐carrying potential, but the in vivo healing patterns of their complexes with hABMSC could be affected by the microenvironment on the surfaces of the scaffolds. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 515–524, 2016.Keywords
Funding Information
- National Research Foundation of Korea (NRF) (2012R1A2A4A01007124)
- Bio & Medical Technology Development Program of the National Research Foundation (NRF) (2012M3A9B2052521)
This publication has 39 references indexed in Scilit:
- Acquisition of human alveolar bone‐derived stromal cells using minimally irrigated implant osteotomy: in vitro and in vivo evaluationsJournal of Clinical Periodontology, 2012
- Candidates Cell Sources to Regenerate Alveolar Bone from Oral TissueInternational Journal of Dentistry, 2012
- In vitro study of the biological interface of Bio‐Oss: implications of the experimental setupClinical Oral Implants Research, 2011
- Isolation and characterization of human periodontal ligament (PDL) stem cells (PDLSCs) from the inflamed PDL tissue: in vitro and in vivo evaluationsJournal of Clinical Periodontology, 2011
- Histological and histomorphometrical analyses of biopsies harvested 11 years after maxillary sinus floor augmentation with deproteinized bovine and autogenous boneClinical Oral Implants Research, 2010
- Controlling Stem Cell Fate with Material DesignAdvanced Materials, 2009
- Scaffolding in tissue engineering: general approaches and tissue-specific considerationsEuropean Spine Journal, 2008
- Characterization of human bone cells derived from the maxillary alveolar ridgeClinical Oral Implants Research, 2006
- Effects of Laddecreg; on the formation of calcified bone matrix in rat calvariae cells cultureBiomaterials, 1999
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991